Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice

Infection and Immunity

Volumn 73, Issue 3, 2005, Pages 1723-1734

  Little, C Scott ^a   Bowe, Andrew ^a   Lin, Richard ^a   Litsky, Jason ^a   Fogel, Robert M ^a   Balin, Brian J ^a   Fresa Dillon, Kerin L ^a  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; MOUSE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; ANIMAL; BACTERIAL INFECTION; BAGG ALBINO MOUSE; BRAIN; HEART MUSCLE; HOSPITALIZATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADMINISTRATION, INTRANASAL; AGING; ANIMALS; BRAIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HEART; LUNG; MICE; MICE, INBRED BALB C; MYOCARDIUM; SEVERITY OF ILLNESS INDEX;

EID: 15544368762     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.3.1723-1734.2005     Document Type: Article

References (53)

1. Abrams, J. T., B. J. Balin, and E. C. Vonderheid. 2001. Association between Sezary T cell-activating factor, Chlamydia pneumoniae, and cutaneous T-cell lymphoma. Ann. N. Y. Acad. Sci. 941:69-85.
2. Airenne, S., H. M. Surcel, H. Alakarppa, K. Laitinen, J. Paavonen, P. Saikku, and A. Laurila. 1999. Chlamydia pneumoniae infection in human monocytes. Infect. Immun. 67:1445-1449. (Erratum, 67:6716.)
3. Airenne, S., H. M. Surcel, A. Bloigu, K. Laitinen, P. Saikku, and A. Laurila. 2000. The resistance of human monocyte-derived macrophages to Chlamydia pneumoniae infection is enhanced by interferon-gamma. Apmis 108:139-144.
4. Anton, E., A. Otegui, and A. Alonso. 2000. Meningoencephalitis and Chlamydia pneumoniae infection. Eur. J. Neurol. 7:586.
5. Balin, B. J., H. C. Gerard, E. J. Arking, D. M. Appelt, P. J. Branigan, J. T. Abrams, J. A. Whittum-Hudson, and A. P. Hudson. 1998. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. 187:23-42.
6. Belland, R. J., S. P. Ouellette, J. Gieffers, and G. I. Byrne. 2004. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol. 6:117-127.
7. Blessing, E., T. M. Lin, L. A. Campbell, M. E. Rosenfeld, D. Lloyd, and C. Kuo. 2000. Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect. Immun. 68:4765-4768.
8. Boman, J., S. Soderberg, J. Forsberg, L. S. Birgander, A. Allard, K. Persson, E. Jidell, U. Kumlin, P. Juto, A. Waldenstrom, and G. Wadell. 1998. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J. Infect. Dis. 178:274-277.
9. Buljevac, D., R. P. Verkooyen, B. C. Jacobs, W. Hop, L. A. van der Zwaan, P. A. van Doom, R. Q. Hintzen, J. Ngeh, S. Gupta, C. Goodbourn, B. Panayiotou, G. McElligott, M. Ferrari, A. Poli, M. Olivieri, G. Verlato, S. Tardivo, M, Nicolis, C. Campello, A. Schumacher, A. B. Lerkerod, I. Seljeflot, L. Sommervoll, I. Holme, J. E. Otterstad, and H. Arnesen. 2003. Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients. Ann. Neurol. 54:828-831.
10. Burnett, M. S., C. A. Gaydos, G. E. Madico, S. M. Glad, B. Paigen, T. C. Quinn, and S. E. Epstein. 2001. Atherosclerosis in apoE knockout mice infected with multiple pathogens. J. Infect. Dis. 183:226-231.
11. Campbell, L. A., and C. C. Kuo. 2003. Chlamydia pneumoniae and atherosclerosis. Semin. Respir. Infect. 18:48-54.
12. Campbell, S., P. S. Yates, F. Waters, and S. J. Richmond. 1991. Purification of Chlamydia trachomatis by a simple and rapid filtration method. J. Gen. Microbiol. 137:1565-1569.
13. Carlisle, S. S., and M. C. Nahata. 1999. Chlamydia pneumoniae and coronary heart disease. Ann. Pharmacother. 33:615-622.
14. Clementsen, P., H. Permin, and S. Norn. 2002. Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease. J. Investig. Allergol. Clin. Immunol. 12:73-79.
15. Cunha, B. A. 1998. The chlamydial pneumonias. Drugs Today 34:1005-1012.
16. Falck, G., L. Heyman, J. Gnarpe, and H. Gnarpe. 1994. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand. J. Infect. Dis. 26:179-187.
17. Ferguson, F. G., A. Wikby, P. Maxson, J. Olsson, and B. Johansson. 1995. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J. Gerontol. A Biol. Sci. Med. Sci. 50:B378-B382.
18. Gaede, K. I., G. Wilke, L. Brade, H. Brade, M. Schlaak, and J. Muller-Quernheim. 2002. Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae. Eur. Respir. J. 19:267-274.
19. Gavazzi, G., and K. H. Krause. 2002. Ageing and infection. Lancet Infect. Dis. 2:659-666.
20. Grayston, J. T. 1992. Chlamydia pneumoniae, strain TWAR pneumonia. Annu. Rev. Med. 43:317-323.
21. Grayston, J. T., L. A. Campbell, C. C. Kuo, C. H. Mordhorst, P. Saikku, D. H. Thom, and S. P. Wang. 1990. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 161:618-625.
22. Guglielminotti, J., N. Lellouche, E. Maury, M. Alzieu, B. Guidet, and G. Offenstadt. 2000. Severe meningoencephalitis: an unusual manifestation of Chlamydia pneumoniae infection. Clin. Infect. Dis. 30:209-210.
23. Hannu, T., M. Puolakkainen, and M. Leirisalo-Repo. 1999. Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology 38:411-414.
24. Hudson, A. P., H. C. Gerard, J. A. Whittum-Hudson, D. M. Appelt, and B. J. Balin. 2000. Chlamydia pneumoniae, APOE genotype, and Alzheimer's disease. Springer-Verlag, New York, N.Y.
25. Hyman, C. L., P. M. Roblin, C. A. Gaydos, T. C. Quinn, J. Schachter, and M. R. Hammerschlag. 1995. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin. Infect. Dis. 20:1174-1178.
26. Jantos, C., P. Artelt, and H. G. Schiefer. 1993. Acute lower respiratory tract infection associated with Chlamydia pneumoniae in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 12:33-35.
27. Johnston, S. L. 1997. Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma. Pediatr. Pulmonol. Suppl. 16:88-89.
28. Korman, T. M., J. D. Turnidge, and M. L. Grayson. 1997. Neurological complications of chlamydial infections: case report and review. Clin. Infect. Dis. 25:847-851.
29. Kuo, C. C., and L. A. Campbell. 2000. Detection of Chlamydia pneumoniae in arterial tissues. J. Infect. Dis. 81:S432-S436.
30. Laurila, A. L., L. Von Hertzen, and P. Saikku. 1997. Chlamydia pneumoniae and chronic lung diseases. Scand. J. Infect. Dis. Suppl. 104:34-36.
31. Layh-Schmitt, G., C. Bendl, U. Hildt, T. Dong-Si, E. Juttler, P. Schnitzler, C. Grond-Ginsbach, and A. J. Grau. 2000. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann. Neurol. 47:652-655.
32. Leinonen, M. 1993. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur. Heart J. 14:57-61.
33. Little, C. S., C. J. Hammond, A. MacIntyre, B. J. Balin, and D. M. Appelt. 2004. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging 25:419-429.
34. MacIntyre, A., R. Abramov, C. J. Hammond, A. P. Hudson, E. J. Arking, C. S. Little, D. M. Appelt, and B. J. Balin. 2003. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J. Neurosci. Res. 71:740-750.
35. MacIntyre, A., C. J. Hammond, C. S. Little, D. M. Appelt, and B. J. Balin. 2002. Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. FEMS Microbiol. Lett. 217:167-172.
36. Marie, I., F. Lecomte, H. Levesque, C. Janvresse, J. M. Kerleau, N. Cailleux, and H. Courtois. 1999. Lofgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: a prospective study. Clin. Infect. Dis. 28:691-692.
37. Miyashita, N., A. Saito, S. Kohno, K. Oizumi, K. Yamaguchi, A. Watanabe, H. Oda, H. Fukano, K. Yoshida, Y. Niki, and T. Matsushima. 2002. Community-acquired Chlamydia pneumoniae pneumonia in Japan: a prospective multicenter community-acquired pneumonia study. Intern. Med. 41:943-949.
38. Mizooka, M., and S. Ishikawa. 2003. Prevalence of Chlamydia pneumoniae in Japanese rural districts; association of smoking and physical activity with Chlamydia pneumoniae seropositivity. Intern. Med. 42:960-966.
39. Moazed, T. C., L. A. Campbell, M. E. Rosenfeld, J. T. Grayston, and C. C. Kuo. 1999. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 180:238-241.
40. Ngeh, J., S. Gupta, C. Goodbourn, B. Panayiotou, and G. McElligott. 2003. Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc. Dis. 15:11-16.
41. Penttila, J. M., M. Anttila, M. Puolakkainen, A. Laurila, K. Varkila, M. Sarvas, P. H. Makela, and N. Rautonen. 1998. Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect. Immun. 66:5113-5118.
42. + T lymphocytes during primary influenza infection. Mech. Ageing Dev. 123:1167-1181.
43. Rink, L., I. Cakman, and H. Kirchner. 1998. Altered cytokine production in the elderly. Mech. Ageing Dev. 102:199-209.
44. Rothfuchs, A. G., D. Gigliotti, K. Palmblad, U. Andersson, H. Wigzell, and M. E. Rottenberg. 2001. IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J. Immunol. 167:6453-6461.
45. + cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma. J. Immunol. 172:2407-2415.
46. Rothstein, N. M., T. C. Quinn, G. Madico, C. A. Gaydos, and C. J. Lowenstein. 2001. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J. Infect. Dis. 183:232-238.
47. Rottenberg, M. E., A. C. Gigliotti Rothfuchs, D. Gigliotti, C. Svanholm, L. Bandholtz, and H. Wigzell. 1999. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J. Immunol. 162:2829-2836.
48. Sahyoun, N. R., H. Lentzner, D. Hoyert, and K. R. Robinson. 2001. Trends in causes of death among the elderly. Aging Trends 1:1-9.
49. Schumacher, A., A. B. Lerkerod, I. Seljeflot, L. Sommervoll, I. Holme, J. E. Otterstad, and H. Arnesen. 2001. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J. Clin. Microbiol. 39:1859-1864.
50. Sriram, S., C. W. Stratton, S. Yao, A. Tharp, L. Ding, J. D. Bannan, and W. M. Mitchell. 1999. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol. 46:6-14.
51. von Hertzen, L. C. 1998. Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease. Ann. Med. 30:27-37.
52. Vuola, J. M., V. Puurula, M. Anttila, P. H. Makela, and N. Rautonen. 2000. Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge. Infect. Immun. 68:960-964.
53. Yoshikawa, T. T. 2000. Epidemiology and unique aspects of aging and infectious diseases. Clin. Infect. Dis. 30:931-933.